NYSE: KMBKimberly Clark Corp Stock
$130.55-0.35 (-0.27%)
Updated Apr 29, 2025
KMB Price
$130.55
Fair Value Price
N/A
Market Cap
$43.32B
52 Week Low
$124.10
52 Week High
$150.45
P/E
17.71x
P/B
39.34x
P/S
2.39x
PEG
5.18x
Dividend Yield
2.83%
Revenue
$19.75B
Earnings
$2.47B
Gross Margin
35.5%
Operating Margin
16.6%
Profit Margin
12.5%
Debt to Equity
13.7
Operating Cash Flow
$3B
Beta
0.25
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
KMB Overview
Kimberly-Clark Corporation manufactures personal care and consumer tissue products in the U.S. and internationally. Personal care offerings include disposable diapers, baby wipes, feminine and incontinence care products, and related products. Its brands names are Huggies, Pull-Ups, Little Swimmers, GoodNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and others. Tissue products offered include facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve brand names. Kimberly-Clark was founded in 1872 and is headquartered in Dallas, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine KMB's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Household & Personal Product
Industry Rating
C
KMB
Ranked#15 of 25
Ranked#15 of 25
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $35.04 | C | |
| $4.10 | C | |
| $63.14 | C |
Be the first to know about important KMB news, forecast changes, insider trades & much more!
KMB News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how KMB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
KMB ($130.55) is trading above its intrinsic value of $50.21, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
KMB is good value based on its earnings relative to its share price (17.71x), compared to the US market average (29.19x)
P/E vs Market Valuation
KMB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more KMB due diligence checks available for Premium users.
Valuation
KMB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
17.71x
Industry
25.44x
Market
29.19x
KMB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
KMB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
KMB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
39.34x
Industry
7.28x
KMB is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
KMB price to earnings growth (PEG)
For valuing profitable companies with growth potential
KMB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
KMB's financial health
Profit margin
Revenue
$4.8B
Net Income
$567.0M
Profit Margin
11.7%
KMB's Earnings (EBIT) of $3.28B... subscribe to Premium to read more.
Interest Coverage Financials
KMB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$16.3B
Liabilities
$15.1B
Debt to equity
13.7
KMB's short-term liabilities ($6.92B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KMB's long-term liabilities ($8.16B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KMB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
KMB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$327.0M
Investing
-$119.0M
Financing
-$683.0M
KMB's operating cash flow ($3.12B)... subscribe to Premium to read more.
Debt Coverage Financials
KMB vs Household & Personal Product Stocks
Kimberly Clark Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.